KKUR Stock Price, Chart, Stats & News

ChromoCure, Inc. specializes in designing and delivering exclusive systems for cancer identification. Their primary offering, the Chromosomal Scanner Series 200, is a detection system capable of identifying a distinct genomic characteristic that is universally present in all cancers yet entirely absent in healthy cells. Furthermore, the company dedicates its scientific and technological expertise to investigating non-toxic and non-invasive strategies for both cancer treatment and cure research.